Mizuho raised the firm’s price target on Cigna (CI) to $325 from $307 and keeps an Outperform rating on the shares. The firm updated targets in the healthcare facilities and managed care group as part of a Q4 preview. Mizuho’s physician survey indicated healthcare utilization growth trends decelerated sequentially despite easier year-over-year comps, which could indicate trend is peaking, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Trump Trade: Trump says Venezuela to give U.S. up to 50M barrels of oil
- CVS, UnitedHealth, diverted ‘billions’ from health plans, says Hunterbrook Media
- Trump says he will meet with 14 health insurers in a few days
- Cigna price target raised to $307 from $294 at Bernstein
- Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26